Brain and Behavior Research Foundation

More Rapid Form of Brain Stimulation for Resistant Depression Worked as Well as Conventional TMS

More Rapid Form of Brain Stimulation for Resistant Depression Worked as Well as Conventional TMS

Since 2008, when transcranial magnetic stimulation, or TMS, was approved by the U.S. Food and Drug Administration (FDA), it has been available to people whose depression has resisted conventional forms of treatment. In the decade that has passed, the effectiveness of TMS has been confirmed in a number of clinical trials, showing that as many as half of treatment-resistant patients respond to it (i.e., have at least a 50% reduction in symptoms) and up to one-third achieve remission of symptoms with it.